Lancet Infectious Diseases — Lyme disease vaccination: safety first

About the journal

The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.

Reputation and Impact

The Lancet Infectious Diseases has an Impact Factor of 25·148® and ranks first among infectious diseases journals (2017 Journal Citation Reports®, Clarivate Analytics 2018). The Lancet Infectious Diseases is recognised for providing a global, authoritative, and independent forum for the highest quality infectious diseases research and opinion, covering such areas as the treatment and research of HIV/AIDS, antibiotic resistance, emerging infections, and public health.